Related Experiment Video
Updated: Oct 3, 2025

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited
Leonardo P Suciadi1, Joshua Henrina2, Iwan Cahyo Santosa Putra3
1Cardiology, Siloam Hospitals Kebon Jeruk/Siloam Heart Institute, Jakarta, IDN.
Insights
Iron deficiency is common in chronic heart failure (CHF). Prompt diagnosis and intravenous iron therapy improve symptoms, function, and quality of life in these patients.
Area of Science:
- Cardiology
- Hematology
- Internal Medicine
Background:
- Iron deficiency is highly prevalent in patients with chronic heart failure (CHF).
- Diagnosis is often delayed, with treatment initiated only after anemia becomes apparent.
- Clinical practice guidelines emphasize the need for proper management of iron deficiency in CHF.
Purpose of the Study:
- To review iron homeostasis and its pathophysiologic changes in CHF.
- To discuss the clinical implications of iron deficiency in CHF patients.
- To outline the progression of clinical trials for iron deficiency treatment in CHF.
Main Methods:
- Comprehensive literature review of iron homeostasis, pathophysiology, and clinical trials.
- Analysis of studies on iron supplementation in heart failure patients.
- Examination of current clinical practice guidelines.
Main Results:
- Iron deficiency significantly worsens clinical outcomes in CHF patients.
- Iron supplementation, especially intravenous, improves symptoms, functional capacity, and quality of life.
- Routine screening for iron status is recommended for all newly diagnosed heart failure patients.
Conclusions:
- Current guidelines recommend screening all heart failure patients for iron deficiency.
- Intravenous iron replacement is advised for symptomatic heart failure patients with iron deficiency, even without anemia.
Abstract:
Iron deficiency is prevalent in chronic heart failure (CHF) patients. Nonetheless, the diagnosis is often overlooked and, often, the treatment is commenced just when overt anemia has ensued. Therefore, a better appreciation of this disease is needed, and all seasoned cardiologists should know how to approach CHF patients with iron deficiency correctly, as mandated by clinical practice guidelines. In this comprehensive review, we describe iron homeostasis, the pathophysiologic changes of iron homeostasis, and the clinical implications of iron deficiency on CHF patients. In addition, we delineate the evolution of clinical trials, ranging from the inception to the ongoing clinical trials of iron deficiency treatment in CHF patients. Iron deficiency contributes to the worse clinical outcome of the patients. Numerous studies have reported the clinical benefit of iron supplementation, particularly in intravenous preparation, in heart failure patients regarding symptoms, functional capacity, and quality of life (QoL) improvement. Therefore, the current guidelines recommend routine screening of iron status in all newly diagnosed heart failure patients. Eventually, intravenous iron replacement is recommended for symptomatic heart failure patients with iron deficiency, irrespective of anemia.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology